Study Of Tranexamic Acid For The Reduction Of Blood Loss In Patients Undergoing Major Abdominal Surgery
Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
Tranexamic acid has been shown to reduce postoperative blood losses and transfusion
requirements in various types of major surgery (orthopedic surgery, spine surgery,
cardiopulmonary bypass, liver resections, and gynecological cancers).The current trial is
being conducted to compare the efficacy of tranexamic acid plus standard of care versus
standard of care in reduction of blood loss in patients undergoing major abdominal surgeries.